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What medical biochemist should 
know about tuberculosis infection?
Slavica Dodig 
Department for Clinical Laboratory Diagnosis, Srebrnjak 
Children’s Hospital, Zagreb, Croatia
Immune response to M . tuberculosis is a classic ex-
ample of the cell-mediated immunity . After up-
take of M . tuberculosis in alveolar macrophages a 
several scenarios are possible: in healthy subjects 
M . tuberculosis may be destroyed immediately (in 
this case no adaptive T-cell response is developed) . 
Mycobacteria which escape this destruction will 
multiply and macrophages will be disrupted . In-
flammatory cells, including blood monocytes are 
attracted to the lung . Monocytes will differentiate 
into macrophages and ingest (not destroy) myco-
bacteria, so mycobacteria may multiply logarithm-
mically . Within 2 fo 6 weeks, T- cell-mediated im-
munity develops, i .e . antigen-specific T-lympho-
cytes arrive, proliferate, and activate macrophages 
(resulting in granuloma formation) to kill the intra-
cellular mycobacteria . Subsequently, central ne-
crosis inhibits extracellular growth of M . tuberculo-
sis . In 90% of people infection may become dor-
mant, and 10% of people may develop tuberculo-
sis (TB) . Protective anti-mycobacterial immunity 
involves many T-lymphocytes activating the mac-
rophages and their microbicidal functions . Their 
activation requires the release of numerous cy-
tokines, such as IL-12, IL-10, interferon-gamma 
(IFN-γ) or tumour necrosis factor alpha (TNF-α) .
Young children and elderly persons have the high-
est risk of development TB, since they have rela-
tively weak immune defences, because of imma-
ture system (children) or age-related immune dis-
function (elderly people) . Persons with impaired 
immunity due to HIV infection or patients who 
must receive anti-TNF-α medication are at high 
risk of TB development . 
Microbiologic techniques (eg . finding of M . tuber-
culosis in culture) enable detection M . tuberculosis 
in biological specimens, and biochemical meth-
ods (eg . ex vivo determination of IFN-γ) enable de-
tection tuberculosis infection even in latent stage .
Tuberculosis and anti-cytokine 
therapy
Branimir Anić, Mislav Cerovec
Division of Clinical Immunology and Rheumatology, 
Department of Internal Medicine, University of Zagreb School 
of Medicine, Clinical Hospital Center Zagreb 
Patients with rheumatoid arthritis, RA, have great-
er rates of infections comparing with general pop-
ulation . Most common infections are respiratory 
tract infections and also skin and soft tissue infec-
tions . Treatment guidelines imply decisive and ag-
gressive immunosupressive treatment early in the 
course of the disease, just after the diagnosis of RA 
is established . The introduction of biological drugs 
has increased the risk of tuberculosis, especially in 
the case with the use of drugs that inhibit tumor 
necrosis factor alpha, TNF-α . 
TNF-α, especially transmembrane TNF-α, plays an 
important role in innate immunity and immune 
defense focused on Mycobacterium tuberculosis . 
The mechanisms that are inhibited by using anti-
TNF-α drugs are important for maintaining the la-
tent phase of tuberculosis (LTBI - latent tuberculo-
sis infection) . The key role of TNF-α in the defense 
against tuberculosis has been showed in the ex-
periments with knock-out mice which showed 
that the cytokine TNF-α is necessary for granulo-
ma formation and its maintenance, and that it 
have equally important role in the macrophages 
activation . Excessive inhibition of TNF-α leads to 
exacerbation of TB . 
The importance of careful screening of patients 
for tuberculosis before the introduction of biologi-
cal drugs in to the treatment of inflammatory 
rheumatic diseases was also recognized by the 
Croatian Society for Rheumatology and the Croa-
tian Respiratory Society, so the joint guidelines for 
the diagnosis of latent tuberculosis in vaccinated 
patients before the introduction of anti-TNF-α 
therapy were adopted . Early introduction and ap-
plication of these guidelines results in a low occur-
rence of tuberculosis in Croatian patients on bio-
logical therapies .
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Tuberculosis in HIV infected patients
Josip Begovac 
University Hospital for Infectious Disease, University of Zagreb 
School of Medicine
Because of the high burden of disease in devel-
oped countries, Mycobacterium tuberculosis infec-
tion is the most common opportunistic disease in 
HIV infected patients . In Croatia, tuberculosis is the 
second most common opportunistic infection di-
agnosed in HIV infected individuals . Despite re-
cent advances, the diagnosis of tuberculosis is still 
challenging and empiric antituberculosis therapy 
is still necessary, particularly in resource limited 
settings . 
A diagnostic algorithm including assessment of 
symptoms (fever, cough, and night sweats), chest 
radiography, sputum smear examination and CD4 
cell counts determination can be used to reliable 
exclude the diagnosis of tuberculosis in HIV in-
fected patients . In smear negative specimens new 
diagnostic tools such as Xpert MTB/RIF can im-
prove the diagnostic yield . In the early stages of 
HIV-infection the clinical symptoms of tuberculo-
sis are similar to those in HIV-negative patients . 
Extrapulmonary tuberculosis occurs predomi-
nantly in patients with CD4+ cells below 200/
mm3, most commonly affecting the cervical 
lymph nodes . Other extrapulmonary manifesta-
tions include tuberculosis meningitis, miliary or 
disseminated tuberculosis, however, any organ 
system can be involved . 
Simultaneous antiretroviral and antituberculosis 
therapy is challenging because of the associated 
mortality of tuberculosis in severe immunodefi-
ciency, the so called immune reconstruction syn-
drome and drug interactions . Treatment of tuber-
culosis has a priority . However, several studies 
found that the earlier antiretroviral treatment in 
patients with tuberculosis, particularly in patients 
with less than 50 CD4+ cells/mm3 or less than 200 
CD4+ cells is associated with less mortality . Hence 
it is recommended to start antiretroviral therapy 
within two-weeks of antituberculosis therapy in 
patients with 50-100 CD4+ cells/mm3 .
Laboratory diagnosis of latent 
tuberculosis infection
Renata Zrinski Topić
Department of Clinical Laboratory Diagnosis, Srebrnjak 
Children’s Hospital, Zagreb, Croatia
Laboratory diagnosis of latent tuberculosis infec-
tion (LTBI) is based on the measurement of the host 
immune response against Mycobacterium (M .) tu-
berculosis . The blood test determining interferon-
gamma (IFN-γ) released from effector T-lympho-
cytes (interferon-gamma release assay, IGRA) upon 
stimulation with M . tuberculosis specific peptides .
The differences between two commercially availa-
ble IGRAs are the type of sample (whole peripher-
al blood or purified peripheral blood mononuclear 
cells), the number of specific antigens for ex vivo 
stimulation and the method for detection of IFN-γ 
production (the enzyme-linked immunosorbent 
assay determines IFN-γ concentration and the en-
zyme-linked immunosorbent spot determines the 
percentage IFN-γ releasing lymphocyte) .
The high specificity (about 99%) and sensitivity 
(65-95%) of IGRAs supports the use of IGRAs in the 
diagnosis of LTBI in risk individuals but predictive 
values of IGRAs to predict risk for reactivation of 
LTBI to active tuberculosis are not known at this 
moment .
The advantage of IGRAs is the possibility of perfor-
mance quality control . Positive control is used to 
assess the preanalytical factors as patient’s immune 
status and sample manipulation while negative 
control offers an insight into the nonspecific IFN-γ 
level present in the circulation or indicates the pres-
ence of interference antibodies in the sample . The 
unsatisfactory result for control sample is classified 
as the uninterpretable result of IGRAs . The disad-
vantage of IGRAs is their inability to distinguish be-
tween latent and active tuberculosis infection .
The introduction of IGRAs to routine clinical prac-
tice has improved the diagnosis of LTBI but each 
national tuberculose control program should eval-
uate IGRAs for their own occasion .
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Indeterminate results of ex vivo 
Interferon-gamma determination in 
non-immunosuppressed children
Ivan Pavić1, Renata Zrinski Topić2
1Department for Pulmology, Allergology and Clinical 
Immunology, Children’s Hospital Zagreb, Zagreb, Croatia
2Department of Clinical Laboratory Diagnosis, Srebrnjak 
Children’s Hospital, Zagreb, Croatia
Immunosuppressed individuals due to pathologic 
conditions (eg . HIV infection, hematologic malig-
nancies, chronic renal failure) or therapeutic proce-
dures (eg . organ transplantation, chemotherapy, im-
munosuppressive therapy with tumor necrosis fac-
tor α (TNF-α), therapy with systemic corticosteroids) 
are at high risk for reactivation of latent tuberculosis 
infection (LTBI), and require timely identification . 
Laboratory diagnosis of LTBI is based on the blood 
test determining interferon-gamma (IFN-γ) re-
leased from effector T-lymphocytes (interferon-
gamma release assay, IGRA) upon stimulation with 
M . tuberculosis specific peptides .
Two children with indeterminate results of IGRA 
are presented . They were free from congenital or 
acquired immunodeficiency disorders, as shown 
by their history data, clinical examination and lab-
oratory findings . 
Case 1: a 15-month-old male infant was referred for 
testing because of cough and febrile condition per-
sisting for a week before admission . Status: febrile, 
eupneic, pale, tachycardia, serous nasal discharge, 
pharyngeal congestion, normal breath sounds over 
lungs on auscultation . Examination and test find-
ings indicated the diagnosis of pneumonia . 
Case 2: a 5 .5-year-old female child was referred for 
testing due to persistent cough and subfebrile con-
dition with serous nasal discharge for three days 
before admission . She was positive for contact with 
tuberculosis patient, as her uncle has been treated 
for microbiologically positive lung tuberculosis 3 
years before . Examination and test findings indi-
cated the diagnosis of lung tuberculosis . 
As no indeterminate results were found on repeat 
IGRA, it was assumed that acute bacterial inflam-
mation (acute pneumonia or tuberculosis), could 
produce the indeterminate results recorded on ini-
tial testing . In acute inflammation IGRA should be 
delayed .
Ex vivo determination of IFN-γ in 
health care workers
Slavica Dodig1, Renata Zrinski Topić1, Jadranka Živčić1, Ivan Pavić2
1Department of Clinical Laboratory Diagnosis, Srebrnjak 
Children’s Hospital, Zagreb, Croatia
2Department for Pulmology, Allergology and Clinical 
Immunology, Children’s Hospital Zagreb, Zagreb, Croatia
Detection and follow-up the blood test determin-
ing interferon-gamma (IFN-γ) released from effec-
tor T-lymphocytes (interferon-gamma release as-
say, IGRA) upon stimulation with M . tuberculosis 
specific peptides should be performed in subjects 
at an increased risk of M . tuberculosis infection 
such as health care workers (HCW) in chest hospi-
tal and immunocompromised subjects . 
Two cases of HCW with type 1 diabetes mellitus 
(T1DM) and positive anti-thyroglobulin (anti-Tg) 
autoantibodies, respectively, are presented . 
Case 1: a 46 year-old female HCW who has been 
having T1DM for 20 years underwent routine 
screening for Latent tuberculosis infection (LTBI) . 
She was not acutely ill, she had normal body tem-
perature, was eupneic and lung auscultation show 
normal breathing . Tuberculin skin test (TST) was 
negative and IGRA was positive (4 .7 kIU/L) . Positive 
IGRA indicated the LTBI, while TST result was false 
negative . Antituberculosis prophilaxis was not used . 
Case 2: a 57 year-old clinically healthy female was in-
cluded in an annual screeding for LTBI . Initial testing 
showed positive TST and IGRA (5 .2 kIU/L) and ele-
vated levels of anti-Tg (86 .4 kIU/L) . She was free from 
acute disease, afebrile, eupneic, with normal breath 
sounds on auscultation . One year later IGRA was still 
positive . Antituberculosis prophilaxis was not used . 
Although isoniazid prophylaxis was not used in 
these subjects, tuberculosis did not develop dur-
ing the 4-year follow-up period .
